GDF15-GFRAL screening tools developed by Sygnature Discovery support the creation of multimodal assay systems for comprehensive target characterization. These custom assays enable functional readouts across key signalling pathways, facilitating drug discovery efforts focused on GDF15-GFRAL interactions within metabolic and apetite regulation research.
Introduction
As a distant member of the transforming growth factor-beta (TGF-β) superfamily, Growth Differentiation Factor 15 (GDF15) functions through its receptor, Glial cell-derived neurotrophic factor (GDNF) family receptor alpha-like (GFRAL). Recently, the GDF15-GFRAL-RET signalling complex has emerged as a focal point for research, with RET acting as a co-receptor for GFRAL and facilitating downstream signalling pathways.
Figure 1. Schematic representation of GDF15-GFRAL-RET complex signalling pathway.
This collaboration underscores the multifunctional nature of GDF15-GFRAL-RET, impacting pathways critical for cellular stress response and energy balance. Given its regulatory influence across broad physiological systems, this pathway presents new therapeutic opportunities, particularly in areas such as metabolic disorders and cancer.
